News

OptimizeRx Launches TelaRep™ to Support Physicians Treating Patients with Complex Diseases in COVID-19 World

02 April 2020

On-Demand Virtual Consults with Medical Science Liaisons Help Providers Create the Right Treatment Regimen for Patients Needing Specialty Drugs

ROCHESTER, Mich., April 02, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has launched TelaRep™, its latest EHR-enabled digital health tool designed to support physicians who are treating patients with specialty drug therapies.

Read the press release here.

 

“The COVID-19 pandemic has hit our national healthcare system just as there has been an increasing use of complex, expensive specialty drugs. In order to design the best therapeutic treatment regimen for their patients, healthcare providers need detailed information about these powerful specialty medications. Combined with other existing restrictions on visits by life science representatives, social distancing makes in-person consults nearly impossible. We created TelaRep™ to fill this communication gap.”

Steve Silvestro
CCO, OptimizeRx
FIND US AT THE POINT OF CARE

WE INTEGRATE DIRECTLY INTO THE EHR

SCHEDULE A DEMO